Skip to content
Independent analysis of NHS open data
PharmaInsight

Emtricitabine/Rilpivirine/Tenofovir alafenamide vs Valaciclovir

National NHS prescribing compared (Prescription Cost Analysis)
Data updated April 2026

Valaciclovir was dispensed 6,824.0× as often as Emtricitabine/Rilpivirine/Tenofovir alafenamide in April 2026 — 6,824 items versus 1 in England.

1items

Emtricitabine/Rilpivirine/Tenofovir alafenamide · April 2026

NHSBSA Prescription Cost Analysis

6,824items

Valaciclovir · April 2026

NHSBSA Prescription Cost Analysis

Figure 1. Emtricitabine/Rilpivirine/Tenofovir alafenamide versus Valaciclovir: national items dispensed by month

▬ Emtricitabine/Rilpivirine/Tenofovir alafenamide   ·   ╌ Valaciclovir

0 3k 7k Jan 2026 Apr 2026 Valaciclovir 1 Jan 2026: 2 Apr 2026: 1

Source: NHSBSA Prescription Cost Analysis, to April 2026

Emtricitabine/Rilpivirine/Tenofovir alafenamide versus Valaciclovir, April 2026
Measure Emtricitabine/Rilpivirine/Tenofovir alafenamide Valaciclovir
Items, April 2026 1 6,824
Items, last 12 months 3 76,064
Net ingredient cost, April 2026 £491 £399,058

See the full profile for Emtricitabine/Rilpivirine/Tenofovir alafenamide or Valaciclovir.